Henry Schein Inc.
HSIC | NASDAQ
$84.88
-$1.56 (-1.80%)
At close: Oct 30, 2026, 4:00 PM ET
$84.88
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 8:53 AM ET
Company Profile
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
Key Executives
| Name | Position |
|---|---|
| Andrea Albertini | Chief Executive Officer of Global Distribution & Technology |
| Frederick Lowery | CEO & Director |
| Christopher Pendergast | Senior Vice President & Chief Technology Officer |
| Michael Saul Ettinger | Executive Vice President & Chief Operating Officer |
| Ronald N. South | Senior Vice President & Chief Financial Officer |
| Christine Sheehy | Senior Vice President & Chief Human Resources Officer |
| Graham Stanley | Vice President of Investor Relations & Strategic Finance Project Officer |
| Kelly Murphy | Senior Vice President & General Counsel |
| Mark E. Mlotek | Executive Vice President & Chief Strategic Officer |
| Olga Timoshkina | VP of Corporate Finance & Chief Accounting Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 22, 2026 | 8-K | Current Report |
| Sep 09, 2026 | 4 | Filing |
| Aug 06, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 04, 2026 | 10-Q | Quarterly Report |
| Aug 04, 2026 | 8-K | Current Report |
| Jul 30, 2026 | 8-K | Current Report |
| Jun 18, 2026 | 11-K | Filing |
| Jun 15, 2026 | 4 | Filing |
| May 29, 2026 | SD | Filing |
| May 28, 2026 | 3 | Filing |
Henry Schein Inc.
| Country | United States |
| IPO Date | Nov 3, 1995 |
| Industry | Medical - Distribution |
| Sector | Healthcare |
| Employees | 25,000 |
| CEO | Frederick Lowery |
Contact Details
135 Duryea Road Melville,
New York 11747 United States
Stock Details
| Ticker Symbol | HSIC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001000228 |
| CUSIP Number | 806407102 |
| ISIN Number | US8064071025 |
| SIC Code | 5047 |
Recent News
- 3 days ago / zacks.comWhy Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term
- 6 days ago / zacks.comAnalysts Estimate Henry Schein (HSIC) to Report a Decline in Earnings: What to Look Out for
- 6 days ago / zacks.comHenry Schein to Report Q3 Earnings: Here's What You Should Know
- 13 days ago / businesswire.comHenry Schein to Webcast Third Quarter 2026 Conference Call on Tuesday, November 3, 2026, at 8:00 a.m. ET
- 14 days ago / zacks.comWhy Henry Schein (HSIC) is a Top Growth Stock for the Long-Term
- 19 days ago / zacks.comHenry Schein (HSIC) is a Top-Ranked Value Stock: Should You Buy?
- 25 days ago / businesswire.comHenry Schein Announces Chief Financial Officer Leadership Transition
- 27 days ago / zacks.comHSIC or MMSI: Which Is the Better Value Stock Right Now?
- 27 days ago / zacks.comShould Value Investors Buy Henry Schein (HSIC) Stock?
- 1 month ago / businesswire.comHenry Schein Cares Marks 25 Years of Helping Health Happen®
Add to Watchlist
Select watchlists to add or remove HSIC